Literature DB >> 11742505

Dlk/ZIP kinase-induced apoptosis in human medulloblastoma cells: requirement of the mitochondrial apoptosis pathway.

D Kögel1, C Reimertz, P Mech, M Poppe, M C Frühwald, H Engemann, K H Scheidtmann, J H Prehn.   

Abstract

Dlk/ZIP kinase is a member of the Death Associated Protein (DAP) kinase family of pro-apoptotic serine/threonine kinases that have been implicated in regulation of apoptosis and tumour suppression. Expression of both Dlk/ZIP kinase and its interaction partner Par-4 is maintained in four medulloblastoma cell lines investigated, whereas three of seven neuroblastoma cell lines have lost expression of Par-4. Overexpression of a constitutively pro-apoptotic deletion mutant of Dlk/ZIP kinase induced significant apoptosis in D283 medulloblastoma cells. Cell death was characterized by apoptotic membrane blebbing, and a late stage during which the cells had ceased blebbing and were drastically shrunken or disrupted into apoptotic bodies. Over-expression of the anti-apoptotic Bcl-xL protein had no effect on Dlk/ZIP kinase-induced membrane blebbing, but potently inhibited Dlk/ZIP kinase-induced cytochrome c release and transition of cells to late stage apoptosis. Treatment with caspase inhibitors delayed, but did not prevent entry into late stage apoptosis. These results demonstrate that Dlk/ZIP kinase-triggered apoptosis involves the mitochondrial apoptosis pathway. However, cell death proceeded in the presence of caspase inhibitors, suggesting that Dlk/ZIP kinase is able to activate alternative cell death pathways. Alterations of signal transduction pathways leading to Dlk/ZIP kinase induced apoptosis or loss of expression of upstream activators could play important roles in tumour progression and metastasis of neural tumours. (c) 2001 Cancer Research Campaign

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11742505      PMCID: PMC2363987          DOI: 10.1054/bjoc.2001.2158

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  42 in total

1.  Death-associated protein kinase-related protein 1, a novel serine/threonine kinase involved in apoptosis.

Authors:  B Inbal; G Shani; O Cohen; J L Kissil; A Kimchi
Journal:  Mol Cell Biol       Date:  2000-02       Impact factor: 4.272

2.  Mitochondrio-nuclear translocation of AIF in apoptosis and necrosis.

Authors:  E Daugas; S A Susin; N Zamzami; K F Ferri; T Irinopoulou; N Larochette; M C Prévost; B Leber; D Andrews; J Penninger; G Kroemer
Journal:  FASEB J       Date:  2000-04       Impact factor: 5.191

3.  Pro-apoptotic action of PAR-4 involves inhibition of NF-kappaB activity and suppression of BCL-2 expression.

Authors:  S Camandola; M P Mattson
Journal:  J Neurosci Res       Date:  2000-07-15       Impact factor: 4.164

Review 4.  Serine/threonine protein kinases and apoptosis.

Authors:  T G Cross; D Scheel-Toellner; N V Henriquez; E Deacon; M Salmon; J M Lord
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

Review 5.  The mitochondrion in cell death control: certainties and incognita.

Authors:  M Loeffler; G Kroemer
Journal:  Exp Cell Res       Date:  2000-04-10       Impact factor: 3.905

Review 6.  Apaf1 and the apoptotic machinery.

Authors:  F Cecconi
Journal:  Cell Death Differ       Date:  1999-11       Impact factor: 15.828

Review 7.  Par-4: an emerging pivotal player in neuronal apoptosis and neurodegenerative disorders.

Authors:  M P Mattson; W Duan; S L Chan; S Camandola
Journal:  J Mol Neurosci       Date:  1999 Aug-Oct       Impact factor: 3.444

8.  Interaction partners of Dlk/ZIP kinase: co-expression of Dlk/ZIP kinase and Par-4 results in cytoplasmic retention and apoptosis.

Authors:  G Page; D Kögel; V Rangnekar; K H Scheidtmann
Journal:  Oncogene       Date:  1999-12-02       Impact factor: 9.867

9.  C-terminal truncation of Dlk/ZIP kinase leads to abrogation of nuclear transport and high apoptotic activity.

Authors:  D Kögel; H Bierbaum; U Preuss; K H Scheidtmann
Journal:  Oncogene       Date:  1999-12-02       Impact factor: 9.867

Review 10.  Extranuclear apoptosis. The role of the cytoplasm in the execution phase.

Authors:  J C Mills; N L Stone; R N Pittman
Journal:  J Cell Biol       Date:  1999-08-23       Impact factor: 10.539

View more
  22 in total

Review 1.  Cancer-selective apoptotic effects of extracellular and intracellular Par-4.

Authors:  T Shrestha-Bhattarai; V M Rangnekar
Journal:  Oncogene       Date:  2010-05-03       Impact factor: 9.867

2.  Phosphorylation of Par-4 by protein kinase A is critical for apoptosis.

Authors:  Sushma Gurumurthy; Anindya Goswami; Krishna Murthi Vasudevan; Vivek M Rangnekar
Journal:  Mol Cell Biol       Date:  2005-02       Impact factor: 4.272

Review 3.  Mechanisms of apoptosis by the tumor suppressor Par-4.

Authors:  Nikhil Hebbar; Chi Wang; Vivek M Rangnekar
Journal:  J Cell Physiol       Date:  2012-12       Impact factor: 6.384

4.  Expression of PAR-4 and PHLDA1 is prognostic for overall and disease-free survival in oral squamous cell carcinomas.

Authors:  Cláudia Malheiros Coutinho-Camillo; Silvia Vanessa Lourenço; Suely Nonogaki; José Guilherme Vartanian; Maria Aparecida Nagai; Luiz Paulo Kowalski; Fernando Augusto Soares
Journal:  Virchows Arch       Date:  2013-06-09       Impact factor: 4.064

5.  Tumour-suppression activity of the proapoptotic regulator Par4.

Authors:  Isabel García-Cao; Angeles Duran; Manuel Collado; Maria J Carrascosa; Juan Martín-Caballero; Juana M Flores; Maria T Diaz-Meco; Jorge Moscat; Manuel Serrano
Journal:  EMBO Rep       Date:  2005-06       Impact factor: 8.807

6.  BH3 mimetics reactivate autophagic cell death in anoxia-resistant malignant glioma cells.

Authors:  Holger Hetschko; Valerie Voss; Christian Senft; Volker Seifert; Jochen H M Prehn; Donat Kögel
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

Review 7.  Apoptosis and tumor resistance conferred by Par-4.

Authors:  Yanming Zhao; Vivek M Rangnekar
Journal:  Cancer Biol Ther       Date:  2008-12-08       Impact factor: 4.742

8.  Development of a novel prostate apoptosis response-4 (Par-4) protein entity with an extended duration of action for therapeutic treatment of cancer.

Authors:  Kyungbo Kim; Pereira Araujo; Nikhil Hebbar; Ziyuan Zhou; Xirong Zheng; Fang Zheng; Vivek M Rangnekar; Chang-Guo Zhan
Journal:  Protein Eng Des Sel       Date:  2019-12-13       Impact factor: 1.650

9.  In vivo far-red luminescence imaging of a biomarker based on BRET from Cypridina bioluminescence to an organic dye.

Authors:  Chun Wu; Kazuhiro Mino; Hidetoshi Akimoto; Makiko Kawabata; Koji Nakamura; Michitaka Ozaki; Yoshihiro Ohmiya
Journal:  Proc Natl Acad Sci U S A       Date:  2009-09-08       Impact factor: 11.205

10.  Selective inhibitors of nuclear export block pancreatic cancer cell proliferation and reduce tumor growth in mice.

Authors:  Asfar S Azmi; Amro Aboukameel; Bin Bao; Fazlul H Sarkar; Philip A Philip; Michael Kauffman; Sharon Shacham; Ramzi M Mohammad
Journal:  Gastroenterology       Date:  2012-10-23       Impact factor: 22.682

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.